Control of microRNA expression as a new way for resveratrol to deliver its beneficial effects

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 36, 2012, Pages 8783-8789

  Lançon, Allan ^a   Kaminski, Jacques ^a   Tili, Esmerina ^b   Michaille, Jean Jacques ^a   Latruffe, Norbert ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

cancer; grape; inflammation; metabolic disease; microRNAs; muscle; resveratrol; wine

Indexed keywords

CANCER; GRAPE; INFLAMMATION; METABOLIC DISEASE; MICRORNAS; RESVERATROL;

CELL CULTURE; DISEASES; FRUITS; METABOLISM; MUSCLE; PATHOLOGY; PHENOLS; RNA;

WINE;

MICRORNA; PLANT EXTRACT; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL; CHEMISTRY; CONFERENCE PAPER; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NEOPLASM; VITIS;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NEOPLASMS; PLANT EXTRACTS; STILBENES; VITIS;

VITACEAE;

EID: 84866429138     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf301479v     Document Type: Conference Paper

References (51)

1. Rifler, J.-P.; Lorcery, F.; Delmas, D.; Prost, M.; Durand, P.; Riedinger, P.; D'Athis, P.; Hudelot, B.; Ragot, K.; Limagne, E.; Mazué, F.; Lizard, G.; Latruffe, N. Influence of red wine intake in secondary prevention of myocardiac infarct patients Mol. Nutr. Food Res. 2012, 56, 345-517
2. Goldberg, D. M.; Yan, J.; Ng, E.; Diamandis, E. P.; Karumanchiri, A.; Soleas, G.; Waterhouse, A. L. A global survey of trans -resveratrol concentrations in commercial wines Am. J. Enol. Vitic. 1995, 46, 159-165
3. Aggarwal, B. B.; Shishodia, S. Molecular targets of dietary agents for prevention and therapy of cancer Biochem. Pharmacol. 2006, 71, 1397-1421
4. Delmas, D.; Solary, E.; Latruffe, N. Resveratrol: a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe Curr. Med. Chem. 2011, 18, 1100-1021
5. Tili, E.; Michaille, J. J. Resveratrol, microRNAs, inflammation, and cancer J. Nucleic Acids 2011, 2011, 102431
6. Althar, M.; Back, J. H.; Tang, X.; Kim, K. H.; Kopelovich, L.; Bickers, D. R.; Kim, A. L. Resveratrol: a review of preclinical studies for human cancer prevention Toxicol. Appl. Pharmacol. 2007, 224, 274-283
7. Bishayee, A. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials Cancer Prev. Res. (Phila.). 2009, 2, 409-418
8. Renaud, S.; de Lorgeril, M. Wine, alcohol, platelets, and the French paradox for coronary heart disease Lancet 1992, 339, 1523-1526
9. Jeandet, P.; Douillet-Breuil, A. C.; Bessis, R.; Debord, S.; Sbaghi, M.; Adrian, M. Phytoalexins from the Vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity, and metabolism J. Agric. Food Chem. 2002, 50, 2731-2741
10. Ribeiro de Lima, M. T.; Waffo-Tegui, P.; Teissedre, P.-L.; Pujolas, A.; Vercauteren, J.; Cabanis, J.-C.; Merillon, J.-M. Determination of stilbenes (trans -astringin, cis-and trans -piceid and cis-and trans-resveratrol) in Portuguese wines J. Agric. Food Chem. 1999, 47, 2666-2670
11. Ohyama, M.; Tanaka, T.; Ito, T.; Iinuma, M.; Bastow, K. F.; Lee, K. H. Antitumor agents 200. Cytotoxicity of naturally occurring resveratrol oligomers and their acetate derivatives Bioorg. Med. Chem. Lett. 1999, 9, 3057-3060
12. Colin, D.; Limagne, E.; Jeanningros, S.; Jacquel, A.; Lizard, G.; Athias, A.; Gambert, P.; Hichami, A.; Latruffe, N.; Solary, E.; Delmas, D. Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells Cancer Prev. Res. (Phila.). 2011, 4, 1095-1106
13. Delmas, D.; Passilly-Degrace, P.; Jannin, B.; Malki, M. C.; Latruffe, N. Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells Int. J. Mol. Med. 2002, 10, 193-199
14. Timmers, S.; Konings, E.; Bilet, L.; Houtkooper, R. H.; van de Weijer, T.; Goossens, G. H.; Hoeks, J.; van der Krieken, S.; Ryu, D.; Kersten, S.; Moonen-Kornips, E.; Hesselink, M. K.; Kunz, I.; Schrauwen-Hinderling, V. B.; Blaak, E. E.; Auwerx, J.; Schrauwen, P. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans Cell Metab. 2011, 14, 612-622
15. Brown, V. A.; Patel, K. R.; Viskaduraki, M.; Crowell, J. A.; Perloff, M.; Booth, T. D.; Vasilinin, G.; Sen, A.; Schinas, A. M.; Piccirilli, G.; Brown, K.; Steward, W. P.; Gescher, A. J.; Brenner, D. E. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis Cancer Res. 2010, 70, 9003-9011
16. Patel, K. R.; Brown, V. A.; Jones, D. J.; Britton, R. G.; Hemingway, D.; Miller, A. S.; West, K. P.; Booth, T. D.; Perloff, M.; Crowell, J. A.; Brenner, D. E.; Steward, W. P.; Gescher, A. J.; Brown, K. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients Cancer Res. 2010, 70, 7392-7399
17. Howells, L. M.; Berry, D. P.; Elliott, P. J.; Jacobson, E. W.; Hoffmann, E.; Hegarty, B.; Brown, K.; Steward, W. P.; Gescher, A. J. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics, and pharmacodynamics Cancer Prev. Res. (Phila.). 2011, 4, 1419-1425
18. Patel, K. R.; Scott, E.; Brown, V. A.; Gescher, A. J.; Steward, W. P.; Brown, K. Clinical trials of resveratrol Ann. N.Y. Acad. Sci. 2011, 1215, 161-169
19. Calamini, B.; Ratia, K.; Malkowski, M. G.; Cuendet, M.; Pezzuto, J. M.; Santarsiero, B. D.; Mesecar, A. D. Pleiotropic mechanisms facilitated by resveratrol and its metabolites Biochem. J. 2010, 429, 273-282
20. Lin, H. Y.; Lansing, L.; Merillon, J. M.; Davis, F. B.; Tang, H. Y.; Shih, A.; Vitrac, X.; Krisa, S.; Keating, T.; Cao, H. J.; Bergh, J.; Quackenbush, S.; Davis, P. J. Integrin αVβ3 contains a receptor site for resveratrol FASEB J 2006, 10, 1742-1744
21. Bertelli, A.; Bertelli, A. A.; Gozzini, A.; Giovannini, L. Plasma and tissue resveratrol concentrations and pharmacological activity Drugs Exp. Clin. Res. 1998, 24, 133-138
22. Lançon, A.; Delmas, D.; Osman, H.; Thenot, J. P.; Jannin, B.; Latruffe, N. Human hepatic cell uptake of resveratrol: involvement of both carrier mediated and diffusion process Biochem. Biophys. Res. Commun. 2004, 316, 1132-1137
23. Hoshino, J.; Park, E. J.; Kondratyuk, T. P.; Marler, L.; Pezzuto, J. M.; van Breemen, R. B.; Mo, S.; Li, Y.; Cushman, M. Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites J. Med. Chem. 2010, 53, 5033-5043
24. Kondratyuk, T. P.; Park, E. J.; Marler, L. E.; Ahn, S.; Yuan, Y.; Choi, Y.; Yu, R.; van Breemen, R. B.; Sun, B.; Hoshino, J.; Cushman, M.; Jermihov, K. C.; Mesecar, A. D.; Grubbs, C. J.; Pezzuto, J. M. Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity Mol. Nutr. Food Res. 2011, 55, 1249-1265
25. Kosaka, N.; Ochiya, T. Unraveling the mystery of cancer by secretory microRNA: horizontal microRNA transfer between living cells Front. Genet. 2012, 2, 97
26. Grønbaek, M.; Mortensen, E. L.; Mygind, K.; Andersen, A. T.; Becker, U.; Gluud, C.; Sørensen, T. I. Beer, wine, spirits and subjective health J. Epidemiol. Community Health 1999, 53, 721-724
27. Levi, F.; Pasche, C.; Lucchini, F.; Ghidoni, R.; Ferraroni, M.; La Vecchia, C. Epidemiological evidence that resveratrol from grape is inversely related to breast cancer risk. Study on 369 cases vs 602 controls of Swiss women from 1993 to 2003 Eur. J. Cancer Prev. 2005, 14, 139-142
28. Lee, R. C.; Feinbaum, R. L.; Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 1993, 75, 843-866
29. Calin, G. A.; Sevignani, C.; Dumitru, C. D.; Hyslop, T.; Noch, E.; Yendamuri, S.; Shimizu, M.; Rattan, S.; Bullrich, F.; Negrini, M.; Croce, C. M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 2999-3004
30. Tili, E.; Michaille, J.-J.; Gandhi, V.; Plunkett, W.; Sampath, D.; Calin, G. A. MiRNAs and their potential for use against cancer and other diseases Future Oncol. 2007, 3, 521-537
31. Colotta, F.; Allavena, P.; Sica, A.; Garlanda, C.; Mantovani, A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis 2009, 30, 1073-1081
32. Tili, E.; Michaille, J.-J.; Adair, B.; Alder, H.; Limagne, E.; Taccioli, C.; Volinia, S.; Delmas, D.; Latruffe, N.; Croce, C. M. Resveratrol decreases the levels of miR-155 by upregulating miR-663, a new anti-inflammatory microRNA targeting JunB and JunD Carcinogenesis 2010, 31, 1561-1566
33. Tili, E.; Michaille, J. J.; Alder, H.; Volinia, S.; Delmas, D; Latruffe, N.; Croce, C. M. Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells Biochem. Pharmacol. 2010, 80, 2057-2065
34. Bae, S.; Lee, E. M.; Cha, H. J.; Kim, K.; Yoon, Y.; Lee, H.; Kim, J.; Kim, Y. J.; Lee, H. G.; Jeung, H. K; Min, Y. H.; An, S. Resveratrol alters microRNA expression profiles in A549 human non-small cell lung cancer cells Mol. Cells 2011, 32, 243-249
35. Han, Z.; Yang, Q.; Liu, B.; Wu, J.; Li, Y.; Yang, C.; Jiang, Y. MicroRNA-622 functions as a tumor suppressor by targeting K-Ras and enhancing the anticarcinogenic effect of resveratrol Carcinogenesis 2011, 33, 131-139
36. Dhar, S.; Hicks, C.; Levenson, A. S. Resveratrol and prostate cancer: promising role for microRNAs Mol. Nutr. Food Res. 2011, 55, 1219-1229
37. Hagiwara, K.; Kosaka, N.; Yoshioka, Y.; Takahashi, R. U.; Takeshita, F.; Ochiya, T. Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity Sci. Rep. 2012, 2, 314
38. Yu, Y. -H.; Chen, H.-A.; Chen, P.-S.; Cheng, Y.-J.; Hsu, W.-H.; Chang, Y.-W.; Chen, Y.-H.; Jan, Y.; Hsiao, M.; Chang, T.-Y.; Liu, Y.-H.; Jeng, Y.-M.; Wu, C.-H.; Huang, M.-T.; Su, Y.-H.; Hung, M.-C.; Chien, M.-H.; Chen, C.-Y.; Kuo, M.-L.; Su, J.-L. MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol Oncogene 2012, 10.1038/onc.2012.74
39. Lukiw, W. J.; Zhao, Y.; Cui, J. G. An NF-κB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells J. Biol. Chem. 2008, 283, 31315-31322
40. Park, S. J.; Ahmad, F.; Philp, A.; Baar, K.; Williams, T.; Luo, H.; Ke, H.; Rehmann, H.; Taussig, R.; Brown, A. L.; Kim, M. K.; Beaven, M. A.; Burgin, A. B.; Manganiello, V.; Chung, J. H. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases Cell 2012, 148, 421-433
41. Baarine, M.; Thandapilly, S.; Louis, X.; Mazué, F.; Yu, L.; Delmas, D.; Netticadan, T.; Lizard, G.; Latruffe, N. Pro-apoptotic vs anti-apoptotic properties and cell signaling of dietary resveratrol on normal and on tumour cells Genes Nutr. 2011, 6, 161-169
42. Gagan, J.; Dey, B. K.; Dutta, A. MicroRNAs regulate and provide robustness to the myogenic transcriptional network Curr. Opin. Pharmacol. 2012, 12, 1-6
43. Condorelli, G.; Latronico, M. V.; Dorn, G. W., 2nd. microRNAs in heart disease: putative novel therapeutic targets? Eur. Heart J. 2010, 31, 649-658
44. Thum, T.; Gross, C.; Fiedler, J.; Fischer, T.; Kissler, S.; Bussen, M.; Galuppo, P.; Just, S.; Rottbauer, W.; Frantz, S.; Castoldi, M.; Soutschek, J.; Koteliansky, V.; Rosenwald, A.; Basson, M. A.; Licht, J. D.; Pena, J. T.; Rouhanifard, S. H.; Muckenthaler, M. U.; Tuschl, T.; Martin, G. R.; Bauersachs, J.; Engelhardt, S. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts Nature 2008, 456, 980-984
45. Mukhopadhyay, P.; Mukherjee, S.; Ahsan, K.; Bagchi, A.; Pacher, P.; Das, D. K. Restauration of altered micro RNA expression in the ischemic heart with resveratrol PLoS ONE 2010, 5, e15705
46. Kaminski, J.; Lançon, A.; Tili, E.; Aires, V.; Demarquoy, J.; Lizard, G.; Michaille, J.-J.; Latruffe, N. Dietary resveratrol modulates metabolic functions in skeletal muscle cells. J. Food Drug Anal. 2012, 20 (Suppl. 1), 398-401.
47. Chen, J. F.; Mandel, E. M.; Thomson, J. M.; Wu, Q.; Callis, T. E.; Hammond, S. M.; Conlon, F. L.; Wang, D.-Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation Nat. Genet. 2006, 38, 228-233
48. Howitz, K. T.; Bitterman, K. J.; Cohen, H. Y.; Lamming, D. W.; Lavu, S.; Wood, J. G.; Zipkin, R. E.; Chung, P.; Kisielewski, A.; Zhang, L. L.; Scherer, B.; Sinclair, D. A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 2003, 425, 191-196
49. Knutson, M. D.; Leeuwenburgh, C. Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases Nutr. Rev. 2008, 66, 591-596
50. Tonkin, J.; Villarroya, F.; Puri, P. L.; Vinciguerra, M. SIRT1 signaling as potential modulator of skeletal muscle diseases Curr. Opin. Pharmacol. 2012, 12, 1-5
51. Zhu, H.; Wu, H.; Liu, X.; Li, B.; Chen, Y.; Ren, X.; Liu, C. G.; Yang, J. M. Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells Autophagy 2009, 5, 816-823